Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous Rivipansel With rHuPH20 in Healthy Subjects

NCT02217917 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Rivipansel
DRUG: Placebo
DRUG: Rivipansel
DRUG: Rivipansel
DRUG: Placebo

Sponsor

GlycoMimetics Incorporated